Get all your news in one place.
100's of premium titles.
One app.
Start reading
Kiplinger
Kiplinger
Business
Joey Solitro

Novo Nordisk Stock Surges On Weight Loss Drug Data and Analysts Say It's Still a Buy

People walk inside the Novo Nordisk headquarters in Bagsvaerd .

Novo Nordisk (NVO) stock is soaring Friday after the Danish pharmaceutical company reported positive early stage results for its once-weekly weight loss drug Amycretin.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.